Who Paid My Doc Search
Menu
Product Program year 2022 Source: CMS Open Payments

Lioresal (Baclofen)

Drug Severe Spasticity

NDC 70257-563-01

Open in the dashboard

General payments

$106,162

1,365 payments

Research payments

$0

0 payments

Through program year 2022, $106,162 in general payments and $0 in research payments were reported against Lioresal (Baclofen) (Severe Spasticity).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2022 General $820 23
2021 General $22,217 220
2020 General $22,922 279
2019 General $60,203 843

Breakdown

Who paid General payments · program years 2019–2022
  1. Saol Therapeutics Inc. $106,162 1,365 payments
Top recipients General payments · program year 2022
  1. Miguel Escalon Physical Medicine & Rehabilitation · New York, NY $132 16% · 2 payments
  2. Kimberly Heckert Physical Medicine & Rehabilitation · Philadelphia, PA $76 9% · 1 payment
  3. Michael Saulino Physical Medicine & Rehabilitation · Elkins Park, PA $76 9% · 1 payment
  4. Ryan Hafner Physical Medicine & Rehabilitation · Sarasota, FL $76 9% · 1 payment
  5. Brian Aalbers Neurology with Special Qualifications in Child Neurology · Kansas City, MO $66 8% · 2 payments

The top 5 of 18 recipients; each share is of general payments naming this product in 2022.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2022
  1. Physical Medicine & Rehabilitation $410 52% · 6 practitioners
  2. Neurology with Special Qualifications in Child Neurology Psychiatry & Neurology $66 8% · 1 practitioner
  3. Internal Medicine $66 8% · 1 practitioner
  4. Neuromuscular Medicine Psychiatry & Neurology $66 8% · 1 practitioner
  5. Pain Medicine $60 8% · 1 practitioner

The top 5 of 10 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2022
  1. Pennsylvania $153 19% · 2 recipients
  2. Illinois $143 17% · 5 recipients
  3. New York $132 16% · 1 recipient
  4. Wisconsin $93 11% · 2 recipients
  5. Missouri $83 10% · 2 recipients

The top 5 of 10 states; each share is of general payments naming this product in 2022 where a state was reported.

The top 25 states, free in the app

Records

1,365 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record